Nama's AI scorecard currently rates Cellebrite DI Buy (7.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CLBT's P/E ratio?

Cellebrite DI trades at a trailing price-to-earnings ratio of 24.4.

When does CLBT report earnings?

Cellebrite DI's next scheduled report is on Nov 12, 2026. Analysts expect EPS of $0.16.

What is the CLBT price target?

The median analyst price target from 7 analysts is $15.00, with a range of $12.50 – $20.00.

Is CLBT Shariah compliant?

Nama's AAOIFI-style screen reads Cellebrite DI as Can't Tell. A figure the screen needs is missing, so it can't tell.

Nama Insights

Cellebrite DI (CLBT)

Technology · Software Infrastructure · NASDAQ

Cellebrite DI (CLBT) is a Technology company in the Software Infrastructure industry. It has a market capitalization of $3.13B, a trailing price-to-earnings ratio of 24.4 and a free-cash-flow yield of 5.1%. Over the most recent reported fiscal year, revenue grew 18.6% and free cash flow per share grew 10.6%. Nama's AI scorecard rates it Buy, 7.7 out of 10. On 12-month momentum it ranks in the trailing band of its market.

AI scorecard

Buy · 7.7/10

Clearly positive, short of the top band. As of Nov 7, 2026.

Momentum

Trailing · -26.4% over 12 months ex. last

Bottom 20% of its market on the past year's move.

Shariah screen

Can't Tell

A figure the screen needs is missing, so it can't tell.

Off its high

-52.7%

How far the last close sits under the highest price of the past five years.

Market cap	$3.13B
Trailing P/E	24.4
Price / book	5.8
Price / sales	6.1
FCF yield	5.1%
Dividend yield	—
Gross margin	83.0%
Operating margin	10.9%
Net margin	11.4%
Revenue growth (YoY)	+18.6%
Revenue growth (3-yr annual)	+20.7%
EPS growth (YoY)	+19.1%
FCF/share growth (YoY)	+10.6%
Beta	1.1
Exchange	NASDAQ
Sector	Technology
Industry	Software Infrastructure

CLBT earnings

Next report: Nov 12, 2026 (Q3 2026, EPS estimate $0.16). Beat the EPS estimate in 2 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2026	Aug 13, 2026	$0.11	$0.11	+0.0%	$131.14M
Q1 2026	May 14, 2026	$0.12	$0.10	+20.0%	$128.30M
Q4 2025	Feb 11, 2026	$0.14	$0.14	+0.0%	$128.82M
Q3 2025	Nov 12, 2025	$0.14	$0.13	+7.7%	$126.03M

CLBT analyst price target

Median target $15.00 from 7 analysts, ranging $12.50 – $20.00.

Software Infrastructure peers

Ticker	Company	Market cap	P/E
MSFT	Microsoft	$3.94T	29.4
PLTR	Palantir Technologies	$386.44B	112.2
ORCL	Oracle	$361.97B	14.4
PANW	Palo Alto Networks	$256.86B	81.9
CRWD	CrowdStrike	$222.09B	195.4
NET	Cloudflare	$95.70B	224.0
FTNT	Fortinet	$87.31B	34.5
SNPS	Synopsys	$86.32B	32.3

Explore live CLBT data on Nama Insights →

CLBT FAQ

Is CLBT a buy?: Nama's AI scorecard currently rates Cellebrite DI Buy (7.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CLBT's P/E ratio?: Cellebrite DI trades at a trailing price-to-earnings ratio of 24.4.
When does CLBT report earnings?: Cellebrite DI's next scheduled report is on Nov 12, 2026. Analysts expect EPS of $0.16.
What is the CLBT price target?: The median analyst price target from 7 analysts is $15.00, with a range of $12.50 – $20.00.
Is CLBT Shariah compliant?: Nama's AAOIFI-style screen reads Cellebrite DI as Can't Tell. A figure the screen needs is missing, so it can't tell.